GO Main Menu Go Main Contents Go Bottom Menu
  • 6
    [KOL Interview] IBD treatment during COVID-19 pand..
    We interviewed Dr Philip Smith, Consultant Luminal Gastroenterologist, Royal Liverpool Hospital, Liverpool University Hospitals NHS Foundation Trust Honorary Senior Clinical Lecturer, University of Liverpool in the UK. Dr Philip Smith talked about the challenges and future perspectives of inflammatory bowel disease (IBD) treatment facing the COVID-19 pandemic being both a patient and a physician. Watch Dr Philip’s story here:
    2021-12-27
  • 5
    [Patient Interview] Living with IBD during COVID-1..
    We interviewed Salvo Leone, EFCCA Chairperson who talked about unmet needs of inflammatory bowel disease (IBD) patients in existing treatment and changes in treatment approach due to the COVID-19 pandemic. He also addressed the need for attention on patients’ quality of life and quality of care. Watch Salvo’s story here:
    2021-12-27
  • 4
    [Patient Interview] Living with IBD during COVID-1..
    We interviewed Magdalena Sajak-Szcerba, Secretary of the Board, J-elita (Poland) who talked about challenges of living with inflammatory bowel disease (IBD), and how the COVID-19 pandemic has impacted IBD patients on a patient community level. Watch Magdalena’s story here:
    2021-12-27
  • 3
    [Our People] Celltrion Healthcare Employee Intervi..
    We interviewed people at Celltrion Healthcare who are working around the world to deliver breakthrough therapies that transform the lives of our patients. Meet Juliana Luna Paredes, Alberto Farina and Antonio Capezio, who share about what they do, why they do and why they love it.
    2021-12-24
  • 2
    [Our People] Celltrion Healthcare Employee Intervi..
    We interviewed people at Celltrion Healthcare who are working around the world to deliver breakthrough therapies that transform the lives of our patients.Meet Anthony Boteju, Ninni Raiola and Rafael Conde, who share about what they do, why they do and why they love it.
    2021-12-24
  • 1
    [Company News] Celltrion Takes Trio Of Global Gene..
      Celltrion Healthcare is the winner of the 8th Global Generics & Biosimilars Awards 2021 Celltrion Healthcare is pleased to announce that the company has received a trio at the ‘Global Generics & Biosimilars Awards 2021’ held in Milan, Italy on November 10, 2021. The three categories are ‘Global Company of the Year’, ‘Biosimilar Initiative of the Year’ and ‘Value Added Medicine initiative of the Year.’ The awards are renowned for rewarding ‘best practice’ in the generics, biosimilars and value-added medicine industries, while at the same time encouraging improvements in every aspect of the way business is conducted. We are truly grateful for the prestigious recognition for our achievements, and we remain committed to continuing innovative research of developing biosimilars and novel therapeutics.
    2021-11-11